Market Introduction
An asthma spacer is a tube-like device attached to inhalers for better administration of doses. The spacers help the direct administration of medication into the lungs, as well as reduce the chances of side effects, which may occur if mouth and throat come in contact with the medicine. The increasing prevalence of asthma, coupled with growing adoption of asthma inhalers is projected to drive the growth of the asthma spacers market during the forecast period.
Market Overview and Dynamics
The US asthma spacers market is expected to reach US$ 702.27 million by 2027 from US$ 472.92 million in 2019; it is anticipated to at a CAGR of 5.3% from 2020 to 2027. Factors driving the market growth include the increasing prevalence of respiratory conditions such as asthma and chronic obstructive pulmonary disorder (COPD) and rising awareness regarding the benefits of asthma spacers. However, increased risk of adverse effects due to unlicensed prescriptions restrains the growth of the market. The COVID-19 pandemic has heavily impacted the US asthma spacers market as it has led to disrupted supply chain operations in the country. However, the healthcare authorities and government organization in the US are focusing on spreading awareness about COVID-19 among asthmatic patients as they are highly vulnerable to the infections. Such awareness programs are likely to have positive impact on the adoption of asthma spacers due to precautionary measures, which will eventually drive the market up to certain extent.
Key Market Segments
In terms of product, the aerochamber segment held the largest share of the market in 2019; also, the same segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of distribution channel, the retail pharmacy segment held the largest share of the market in 2019; however, the e-commerce segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Asthma and Allergy Foundation of America are a few of the major primary and secondary sources associated with the US asthma spacers market report.
Reasons to Buy Report
US Asthma Spacers Market Segmentation
Asthma Spacers Market – By Product
Asthma Spacers Market – By Distribution Channel
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 472.92 Million |
| Market Size by 2027 | US$ 702.27 Million |
| CAGR (2020 - 2027) | 5.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
United States
|
| Market leaders and key company profiles |
|
The US Asthma Spacers Market is valued at US$ 472.92 Million in 2019, it is projected to reach US$ 702.27 Million by 2027.
As per our report US Asthma Spacers Market, the market size is valued at US$ 472.92 Million in 2019, projecting it to reach US$ 702.27 Million by 2027. This translates to a CAGR of approximately 5.3% during the forecast period.
The US Asthma Spacers Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the US Asthma Spacers Market report:
The US Asthma Spacers Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The US Asthma Spacers Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the US Asthma Spacers Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)